Sfoglia per AUTORE
MUSTO P
Collezione ASL Vercelli

  

Items : 2

Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study. in Blood cancer journal / Blood Cancer J. 2020 May 18;10(5):58. doi: 10.1038/s41408-020-0326-1.

2020
ASL Biella
ASL Asti
AOU Città della Salute di Torino
ASL Vercelli
AO Cuneo
AOU Alessandria

Boccadoro M; Romano A; Sonneveld P; Musto P; Ria R; Giuliani N; Mosca-Siez ML; Marchetti M; Ballanti S; Offidani M; Liberati AM; de Fabritiis P; Monaco F; Cellini C; Gobbi M; Grasso M; Ronconi S; Di Lullo G; Capra A; Zambello R; Belotti A; Petrucci MT; Pescosta N; Mina R; Larocca A;

Safety and efficacy of rituximab plus bendamustine in relapsed or refractory diffuse large B-cell lymphoma patients: an Italian retrospective multicenter study. in Leukemia & lymphoma / Leuk Lymphoma. 2016 Aug;57(8):1823-30. doi: 10.3109/10428194.2015.1106536. Epub 2015 Dec 15.

2016
AOU Città della Salute di Torino
ASL Vercelli

Ghio F; Marino D; Savini P; Musto P; Carli G; Ilariucci F; Zambello R; Santagostino A; Cabras MG; Marasca R; Tani M; Valenti V; Bernuzzi P; Zanlari L; Spina M; Chiappella A; Arcari A; Gentile M; Cox MC; Vallisa D;